4/A

PRIMARY DOCUMENT

Company: Crinetics Pharmaceuticals, Inc.
Filed: August 27, 2018
Period of Report: July 18, 2018
Accession Number: 0001012975-18-001046

View Document ↗ View on SEC.gov ↗